Cancer in resource-limited settings

Journal of Acquired Immune Deficiency Syndromes

Volumn 56, Issue 4, 2011, Pages 297-299

  Krown, Susan E ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER GRADING; CANCER SURVIVAL; DRUG EFFICACY; EDITORIAL; EUROPE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORBIDITY; MORTALITY; NONHODGKIN LYMPHOMA; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SOCIOECONOMICS; UNITED STATES;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DEVELOPING COUNTRIES; HIV INFECTIONS; HUMANS; LYMPHOMA, NON-HODGKIN; SURVIVAL ANALYSIS; UGANDA;

EID: 79952372078     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31820c0b0f     Document Type: Editorial

References (8)

1. Bateganya MH, Stanaway J, Brentlinger PE, et al. Predictors of survival after a diagnosis of non-Hodgkin's lymphoma in a resource-limited setting: a retrospective study on the impact of HIV infection and its treatment. J Acquired Immune Defic Syndr. 2011;56:312-319.
2. Hladik W, Musinguzi J, KirungiW, et al. The estimated burden of HIV/AIDS in Uganda 2005-2010. AIDS. 2008;19:503-510. (Pubitemid 351317292)
3. Kaplan LD, Kahn JO, Crowe S, et al. Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virusassociated non-Hodgkin's lymphoma: results of a randomized trial. J Clin Oncol. 1991;9:929-940.
4. Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non- Hodgkin's lymphoma. N Engl J Med. 1993;328:1002-1006. (Pubitemid 23095683)
5. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:235-242. (Pubitemid 34438862)
6. Farmer D, Frenk J, Knaul FM, et al. Expansion of cancer care and control in countriesof lowandmiddle income: a call toaction.Lancet. 2010;376:1186-1193.
7. Mwanda WO, Orem J, Fu P, et al. Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa. J Clin Oncol. 2009;27:3480-3488.
8. Evans WE, McLeod HL. Pharmacogenomics-drug disposition, drug targets, and side effects. N Engl J Med. 2003;348:538-549. (Pubitemid 36159890)